Latest News
- Researchers create personalized organoid models for rare spinal cancer
A new study adds to a growing body of evidence that organoids are a promising avenue for drug discovery to improve outcomes in patients with cancer.
February 16, 2022 10:00 AM
detail - MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer
An interim analysis of an ongoing UCLA Phase III study indicates that using magnetic resonance imaging (MRI) to guide precisely-focused high-dose radiation treatment for prostate cancer reduced side effects associated with the treatment.
February 15, 2022 9:00 AM
detail - AACR Releases Report Outlining Impact of COVID-19 Pandemic on Cancer Research and Patient Care
The AACR has released a first-of-its-kind report that provides a comprehensive view of the burden of COVID-19 among patients with cancer and the challenges presented by the pandemic in cancer research and patient care.
February 09, 2022 8:00 AM
detail - UCLA Jonsson Comprehensive Cancer Center scientists identify germline signature that predicts side effects from anti-PD1/PDL1 checkpoint therapy
Investigators have identified a germline biomarker signature that successfully predicts which patients will suffer serious side effects that occur in up to three in 10 patients on anti-PD1/PDL1 therapy.
February 03, 2022 8:00 AM
detail - International meta-analysis quantifies impact of three prostate cancer therapy intensification strategies
A new meta-analysis of randomized, controlled clinical trials provides strong support for adding androgen deprivation therapy to definitive radiotherapy for the treatment of prostate cancer.
January 19, 2022 10:00 AM
detail - Genetics predicts toxic side effects to prostate cancer radiotherapy
For the first time, researchers led by a team from the UCLA Jonsson Comprehensive Cancer Center used prostate cancer patients’ DNA to create a model that appears to predict who will have side effects from radiation.
January 14, 2022 10:00 AM
detail - Researchers identify signaling mechanisms in pancreatic cancer cells that could provide treatment targets
UCLA-led research led provides new insights into molecular “crosstalk” in pancreas cancer cells, identifying vulnerabilities that could provide therapeutic drug targets already being studied in several cancers.
January 11, 2022 9:00 AM
detail - Lab-grown organoids, mimicking fallopian tubes, could help prevent ovarian cancer, research shows
UCLA researchers have developed what promises to be a game-changing approach in the treatment of ovarian cancer, a silent killer that often goes undetected until its final stages.
January 06, 2022 6:00 AM
detail - Although they tend to be diagnosed with higher-risk prostate cancer, Black men undergoing radiation therapy have better outcomes than white men
UCLA-led research unexpectedly found that although Black men appeared to have more aggressive disease when they enrolled in clinical trials of radiation therapy for prostate cancer, their outcomes were better than those of their white counterparts.
December 29, 2021 11:00 AM
detail - Model co-created by UCLA Health’s Dr. Beth Karlan provides platform for scientists to study factors that lead to cancer development in BRCA1 mutation carriers
The lifetime risk of developing ovarian cancer is less than 2 percent for the general female population, but for women who carry a mutation in the BRCA1 gene, estimated risk is between 35 and 70 percent.
December 28, 2021 10:00 AM
detail - UCLA Jonsson Comprehensive Cancer Center study details chromosome-level changes that allow melanomas to develop drug resistance
To investigate mutations in a key cancer-promoting genetic pathway, UCLA researchers led the development of a melanoma model of drug resistance, enabling them to study changes that support resistance in cancer cells.
December 20, 2021 11:30 AM
detail - Dr. Andrei Gafita receives award to develop predictive tool for treating patients with advanced prostate cancer
Dr. Andrei Gafita has been named a 2021 Young Investigator Award recipient by the Prostate Cancer Foundation.
December 15, 2021 1:00 PM
detail - UCLA-led study provides first indirect evidence that PSMA PET/CT surpasses conventional imaging in detecting occult prostate cancer spread and predicting long-term course and outcomes
UCLA researchers led a large international study providing what is believed to be the first evidence that a recently approved imaging technique improves risk-stratification and long-term prognostic capabilities for patients with prostate cancer.
December 15, 2021 7:00 AM
detail - SABCS: Subgroup analysis of trastuzumab deruxtecan (T-DXd) shows ‘encouraging’ results in controlling stable brain metastases in HER2-positive metastatic breast cancer
A study analysis led by UCLA researchers found progression-free survival and objective response rate benefit when women with HER2-positive metastatic breast cancer were treated with a HER2-targeting antibody drug when compared to the current standard of treatment.
December 13, 2021 6:00 AM
detail - Anti-cancer drug identified by UCLA researchers shows promise treating high-risk COVID-19 patients
Researchers from UCLA are part of a collaboration of scientists from several universities studying the potential that the anti-cancer drug berzosertib could be effective in treating or preventing SARS-CoV-2, the virus that causes COVID-19.
December 01, 2021 9:00 AM
detail - Joseph Shirk receives grant to study how virtual 3D tumor map can improve bladder cancer surgery
Dr. Joseph D. Shirk has been awarded a 2022 grant for $75,000 from the Margaret E. Early Medical Research Trust.
November 29, 2021 9:00 AM
detail - UCLA research shows why immune checkpoint blockade impedes but does not stop glioblastoma progression
Like locking the door but opening windows, an immune checkpoint therapy temporarily slows glioblastoma (GBM) progression but fails to establish an effective anti-tumor microenvironment, according to studies led by a UCLA research team.
November 26, 2021 9:00 AM
detail - New imaging technology developed by UCLA research team may reduce need for skin biopsies
Instead of surgically removing a sample of skin, sending it to a lab and waiting several days for results, your dermatologist takes pictures of a suspicious-looking lesion and quickly produces a detailed, microscopic image of the skin.
November 18, 2021 12:00 PM
detail - Low-dose lung cancer screenings can reduce death by at least 20%, but usage is low
In this UCLA Health Connect blog, learn how annual screenings improve chances of catching disease early and new guidelines expand opportunities.
November 17, 2021 9:00 AM
detail - UCLA scientists make strides toward an ‘off-the-shelf’ immune cell therapy for cancer
A new study by UCLA researchers report a critical step forward in the development of an “off-the-shelf” cancer immunotherapy using rare but powerful immune cells that could potentially be used to treat a wide range of patients with various cancers.
November 16, 2021 9:00 AM
detail